Home > > > Report Detail

Global Intravenous Solutions Market Growth 2020-2025

Publisher Name :
Date: 15-Sep-2020
No. of pages: 137

According to this study, over the next five years the Intravenous Solutions market will register a 6.5%% CAGR in terms of revenue, the global market size will reach $ 12180 million by 2025, from $ 9471.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous Solutions business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Intravenous Solutions, covering the supply chain analysis, impact assessment to the Intravenous Solutions market size growth rate in several scenarios, and the measures to be undertaken by Intravenous Solutions companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Crystalloids

- Colloids

- Others

- Crystalloids has the highest share of revenue by type, more than 76% in 2019.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Basic IV Solutions

- Nutrient Infusion Solution

- Others

- Basic IV solutions has the highest percentage of sales by application, reaching 65.98% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Baxter

- Kelun Group

- Otsuka

- ICU Medical

- Fresenius Kabi

- B. Braun Melsungen

- Fresenius Kabi

- JW Life Science

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Intravenous Solutions consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Intravenous Solutions market by identifying its various subsegments.

- Focuses on the key global Intravenous Solutions manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Intravenous Solutions with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Intravenous Solutions submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Intravenous Solutions Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Solutions Consumption 2015-2025
2.1.2 Intravenous Solutions Consumption CAGR by Region
2.2 Intravenous Solutions Segment by Type
2.2.1 Crystalloids
2.2.2 Colloids
2.2.3 Others
2.3 Intravenous Solutions Consumption by Type
2.3.1 Global Intravenous Solutions Consumption Market Share by Type (2015-2020)
2.3.2 Global Intravenous Solutions Revenue and Market Share by Type (2015-2020)
2.3.3 Global Intravenous Solutions Sale Price by Type (2015-2020)
2.4 Intravenous Solutions Segment by Application
2.4.1 Basic IV Solutions
2.4.2 Nutrient Infusion Solution
2.4.3 Others
2.5 Intravenous Solutions Consumption by Application
2.5.1 Global Intravenous Solutions Consumption Market Share by Type (2015-2020)
2.5.2 Global Intravenous Solutions Value and Market Share by Type (2015-2020)
2.5.3 Global Intravenous Solutions Sale Price by Type (2015-2020)

3 Global Intravenous Solutions by Company
3.1 Global Intravenous Solutions Sales Market Share by Company
3.1.1 Global Intravenous Solutions Sales by Company (2018-2020)
3.1.2 Global Intravenous Solutions Sales Market Share by Company (2018-2020)
3.2 Global Intravenous Solutions Revenue Market Share by Company
3.2.1 Global Intravenous Solutions Revenue by Company (2018-2020)
3.2.2 Global Intravenous Solutions Revenue Market Share by Company (2018-2020)
3.3 Global Intravenous Solutions Sale Price by Company
3.4 Global Intravenous Solutions Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Intravenous Solutions Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Intravenous Solutions Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Intravenous Solutions by Regions
4.1 Intravenous Solutions by Regions
4.2 Americas Intravenous Solutions Consumption Growth
4.3 APAC Intravenous Solutions Consumption Growth
4.4 Europe Intravenous Solutions Consumption Growth
4.5 Middle East & Africa Intravenous Solutions Consumption Growth

5 Americas
5.1 Americas Intravenous Solutions Consumption by Countries
5.1.1 Americas Intravenous Solutions Consumption by Countries (2015-2020)
5.1.2 Americas Intravenous Solutions Value by Countries (2015-2020)
5.2 Americas Intravenous Solutions Consumption by Type
5.3 Americas Intravenous Solutions Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Intravenous Solutions Consumption by Regions
6.1.1 APAC Intravenous Solutions Consumption by Regions (2015-2020)
6.1.2 APAC Intravenous Solutions Value by Regions (2015-2020)
6.2 APAC Intravenous Solutions Consumption by Type
6.3 APAC Intravenous Solutions Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Intravenous Solutions by Countries
7.1.1 Europe Intravenous Solutions Consumption by Countries (2015-2020)
7.1.2 Europe Intravenous Solutions Value by Countries (2015-2020)
7.2 Europe Intravenous Solutions Consumption by Type
7.3 Europe Intravenous Solutions Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Intravenous Solutions by Countries
8.1.1 Middle East & Africa Intravenous Solutions Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Intravenous Solutions Value by Countries (2015-2020)
8.2 Middle East & Africa Intravenous Solutions Consumption by Type
8.3 Middle East & Africa Intravenous Solutions Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Intravenous Solutions Distributors
10.3 Intravenous Solutions Customer

11 Global Intravenous Solutions Market Forecast
11.1 Global Intravenous Solutions Consumption Forecast (2021-2025)
11.2 Global Intravenous Solutions Forecast by Regions
11.2.1 Global Intravenous Solutions Forecast by Regions (2021-2025)
11.2.2 Global Intravenous Solutions Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Intravenous Solutions Forecast by Type
11.8 Global Intravenous Solutions Forecast by Application

12 Key Players Analysis
12.1 Baxter
12.1.1 Company Information
12.1.2 Intravenous Solutions Product Offered
12.1.3 Baxter Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Baxter Latest Developments
12.2 Kelun Group
12.2.1 Company Information
12.2.2 Intravenous Solutions Product Offered
12.2.3 Kelun Group Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Kelun Group Latest Developments
12.3 Otsuka
12.3.1 Company Information
12.3.2 Intravenous Solutions Product Offered
12.3.3 Otsuka Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Otsuka Latest Developments
12.4 ICU Medical
12.4.1 Company Information
12.4.2 Intravenous Solutions Product Offered
12.4.3 ICU Medical Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ICU Medical Latest Developments
12.5 Fresenius Kabi
12.5.1 Company Information
12.5.2 Intravenous Solutions Product Offered
12.5.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Fresenius Kabi Latest Developments
12.6 B. Braun Melsungen
12.6.1 Company Information
12.6.2 Intravenous Solutions Product Offered
12.6.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 B. Braun Melsungen Latest Developments
12.7 Fresenius Kabi
12.7.1 Company Information
12.7.2 Intravenous Solutions Product Offered
12.7.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Fresenius Kabi Latest Developments
12.8 JW Life Science
12.8.1 Company Information
12.8.2 Intravenous Solutions Product Offered
12.8.3 JW Life Science Intravenous Solutions Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 JW Life Science Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Intravenous Solutions Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Crystalloids
Table 5. Major Players of Colloids
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Intravenous Solutions Consumption Market Share by Type (2015-2020)
Table 9. Global Intravenous Solutions Revenue by Type (2015-2020) ($ million)
Table 10. Global Intravenous Solutions Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Intravenous Solutions Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Intravenous Solutions Consumption Market Share by Application (2015-2020)
Table 14. Global Intravenous Solutions Value by Application (2015-2020)
Table 15. Global Intravenous Solutions Value Market Share by Application (2015-2020)
Table 16. Global Intravenous Solutions Sale Price by Application (2015-2020)
Table 17. Global Intravenous Solutions Sales by Company (2017-2019) (M Units)
Table 18. Global Intravenous Solutions Sales Market Share by Company (2017-2019)
Table 19. Global Intravenous Solutions Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Intravenous Solutions Revenue Market Share by Company (2017-2019)
Table 21. Global Intravenous Solutions Sale Price by Company (2017-2019)
Table 22. Global Intravenous Solutions Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Intravenous Solutions Products Offered
Table 24. Intravenous Solutions Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Intravenous Solutions Consumption by Regions 2015-2020 (M Units)
Table 26. Global Intravenous Solutions Consumption Market Share by Regions 2015-2020
Table 27. Global Intravenous Solutions Value by Regions 2015-2020 ($ Millions)
Table 28. Global Intravenous Solutions Value Market Share by Regions 2015-2020
Table 29. Americas Intravenous Solutions Consumption by Countries (2015-2020) (M Units)
Table 30. Americas Intravenous Solutions Consumption Market Share by Countries (2015-2020)
Table 31. Americas Intravenous Solutions Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Intravenous Solutions Value Market Share by Countries (2015-2020)
Table 33. Americas Intravenous Solutions Consumption by Type (2015-2020) (M Units)
Table 34. Americas Intravenous Solutions Consumption Market Share by Type (2015-2020)
Table 35. Americas Intravenous Solutions Consumption by Application (2015-2020) (M Units)
Table 36. Americas Intravenous Solutions Consumption Market Share by Application (2015-2020)
Table 37. APAC Intravenous Solutions Consumption by Countries (2015-2020) (M Units)
Table 38. APAC Intravenous Solutions Consumption Market Share by Countries (2015-2020)
Table 39. APAC Intravenous Solutions Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Intravenous Solutions Value Market Share by Regions (2015-2020)
Table 41. APAC Intravenous Solutions Consumption by Type (2015-2020) (M Units)
Table 42. APAC Intravenous Solutions Consumption Market Share by Type (2015-2020)
Table 43. APAC Intravenous Solutions Consumption by Application (2015-2020) (M Units)
Table 44. APAC Intravenous Solutions Consumption Market Share by Application (2015-2020)
Table 45. Europe Intravenous Solutions Consumption by Countries (2015-2020) (M Units)
Table 46. Europe Intravenous Solutions Consumption Market Share by Countries (2015-2020)
Table 47. Europe Intravenous Solutions Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Intravenous Solutions Value Market Share by Countries (2015-2020)
Table 49. Europe Intravenous Solutions Consumption by Type (2015-2020) (M Units)
Table 50. Europe Intravenous Solutions Consumption Market Share by Type (2015-2020)
Table 51. Europe Intravenous Solutions Consumption by Application (2015-2020) (M Units)
Table 52. Europe Intravenous Solutions Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Intravenous Solutions Consumption by Countries (2015-2020) (M Units)
Table 54. Middle East & Africa Intravenous Solutions Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Intravenous Solutions Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Intravenous Solutions Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Intravenous Solutions Consumption by Type (2015-2020) (M Units)
Table 58. Middle East & Africa Intravenous Solutions Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Intravenous Solutions Consumption by Application (2015-2020) (M Units)
Table 60. Middle East & Africa Intravenous Solutions Consumption Market Share by Application (2015-2020)
Table 61. Intravenous Solutions Distributors List
Table 62. Intravenous Solutions Customer List
Table 63. Global Intravenous Solutions Consumption Forecast by Countries (2021-2025) (M Units)
Table 64. Global Intravenous Solutions Consumption Market Forecast by Regions
Table 65. Global Intravenous Solutions Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Intravenous Solutions Value Market Share Forecast by Regions
Table 67. Global Intravenous Solutions Consumption Forecast by Type (2021-2025) (M Units)
Table 68. Global Intravenous Solutions Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Intravenous Solutions Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Intravenous Solutions Value Market Share Forecast by Type (2021-2025)
Table 71. Global Intravenous Solutions Consumption Forecast by Application (2021-2025) (M Units)
Table 72. Global Intravenous Solutions Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Intravenous Solutions Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Intravenous Solutions Value Market Share Forecast by Application (2021-2025)
Table 75. Baxter Product Offered
Table 76. Baxter Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 77. Baxter Main Business
Table 78. Baxter Latest Developments
Table 79. Baxter Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors
Table 80. Kelun Group Product Offered
Table 81. Kelun Group Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 82. Kelun Group Main Business
Table 83. Kelun Group Latest Developments
Table 84. Kelun Group Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors
Table 85. Otsuka Product Offered
Table 86. Otsuka Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 87. Otsuka Main Business
Table 88. Otsuka Latest Developments
Table 89. Otsuka Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors
Table 90. ICU Medical Product Offered
Table 91. ICU Medical Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 92. ICU Medical Main Business
Table 93. ICU Medical Latest Developments
Table 94. ICU Medical Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors
Table 95. Fresenius Kabi Product Offered
Table 96. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 97. Fresenius Kabi Main Business
Table 98. Fresenius Kabi Latest Developments
Table 99. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Melsungen Product Offered
Table 101. B. Braun Melsungen Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 102. B. Braun Melsungen Main Business
Table 103. B. Braun Melsungen Latest Developments
Table 104. B. Braun Melsungen Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors
Table 105. Fresenius Kabi Product Offered
Table 106. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors
Table 107. Fresenius Kabi Main Business
Table 108. Fresenius Kabi Latest Developments
Table 109. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 110. JW Life Science Product Offered
Table 111. JW Life Science Intravenous Solutions Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 112. JW Life Science Main Business
Table 113. JW Life Science Latest Developments
Table 114. JW Life Science Basic Information, Company Total Revenue (in $ million), Intravenous Solutions Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Intravenous Solutions
Figure 2. Intravenous Solutions Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Intravenous Solutions Consumption Growth Rate 2015-2025 (M Units)
Figure 5. Global Intravenous Solutions Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Crystalloids
Figure 7. Product Picture of Colloids
Figure 8. Product Picture of Others
Figure 9. Global Intravenous Solutions Consumption Market Share by Type (2015-2020)
Figure 10. Global Intravenous Solutions Value Market Share by Type (2015-2020)
Figure 11. Intravenous Solutions Consumed in Basic IV Solutions
Figure 12. Global Intravenous Solutions Market: Basic IV Solutions (2015-2020) (M Units)
Figure 13. Global Intravenous Solutions Market: Basic IV Solutions (2015-2020) ($ Millions)
Figure 14. Intravenous Solutions Consumed in Nutrient Infusion Solution
Figure 15. Global Intravenous Solutions Market: Nutrient Infusion Solution (2015-2020) (M Units)
Figure 16. Global Intravenous Solutions Market: Nutrient Infusion Solution (2015-2020) ($ Millions)
Figure 17. Intravenous Solutions Consumed in Others
Figure 18. Global Intravenous Solutions Market: Others (2015-2020) (M Units)
Figure 19. Global Intravenous Solutions Market: Others (2015-2020) ($ Millions)
Figure 20. Global Intravenous Solutions Consumption Market Share by Application (2015-2020)
Figure 21. Global Intravenous Solutions Value Market Share by Application (2015-2020)
Figure 22. Global Intravenous Solutions Sales Market Share by Company in 2017
Figure 23. Global Intravenous Solutions Sales Market Share by Company in 2019
Figure 24. Global Intravenous Solutions Revenue Market Share by Company in 2017
Figure 25. Global Intravenous Solutions Revenue Market Share by Company in 2019
Figure 26. Global Intravenous Solutions Sale Price by Company in 2019
Figure 27. Global Intravenous Solutions Consumption Market Share by Regions 2015-2020
Figure 28. Global Intravenous Solutions Value Market Share by Regions 2015-2020
Figure 29. Americas Intravenous Solutions Consumption 2015-2020 (M Units)
Figure 30. Americas Intravenous Solutions Value 2015-2020 ($ Millions)
Figure 31. APAC Intravenous Solutions Consumption 2015-2020 (M Units)
Figure 32. APAC Intravenous Solutions Value 2015-2020 ($ Millions)
Figure 33. Europe Intravenous Solutions Consumption 2015-2020 (M Units)
Figure 34. Europe Intravenous Solutions Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Intravenous Solutions Consumption 2015-2020 (M Units)
Figure 36. Middle East & Africa Intravenous Solutions Value 2015-2020 ($ Millions)
Figure 37. Americas Intravenous Solutions Consumption Market Share by Countries in 2019
Figure 38. Americas Intravenous Solutions Value Market Share by Countries in 2019
Figure 39. Americas Intravenous Solutions Consumption Market Share by Type in 2019
Figure 40. Americas Intravenous Solutions Consumption Market Share by Application in 2019
Figure 41. United States Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 42. United States Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 44. Canada Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 46. Mexico Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Intravenous Solutions Consumption Market Share by Countries in 2019
Figure 48. APAC Intravenous Solutions Value Market Share by Regions in 2019
Figure 49. APAC Intravenous Solutions Consumption Market Share by Type in 2019
Figure 50. APAC Intravenous Solutions Consumption Market Share by Application in 2019
Figure 51. China Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 52. China Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 54. Japan Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 56. Korea Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 58. Southeast Asia Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 59. India Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 60. India Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 62. Australia Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Intravenous Solutions Consumption Market Share by Countries in 2019
Figure 64. Europe Intravenous Solutions Value Market Share by Countries in 2019
Figure 65. Europe Intravenous Solutions Consumption Market Share by Type in 2019
Figure 66. Europe Intravenous Solutions Consumption Market Share by Application in 2019
Figure 67. Germany Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 68. Germany Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 69. France Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 70. France Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 71. UK Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 72. UK Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 74. Italy Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 76. Russia Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Intravenous Solutions Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Intravenous Solutions Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Intravenous Solutions Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Intravenous Solutions Consumption Market Share by Application in 2019
Figure 81. Egypt Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 82. Egypt Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 84. South Africa Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 86. Israel Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 88. Turkey Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Intravenous Solutions Consumption Growth 2015-2020 (M Units)
Figure 90. GCC Countries Intravenous Solutions Value Growth 2015-2020 ($ Millions)
Figure 91. Global Intravenous Solutions Consumption Growth Rate Forecast (2021-2025) (M Units)
Figure 92. Global Intravenous Solutions Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 94. Americas Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 95. APAC Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 96. APAC Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 97. Europe Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 98. Europe Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 100. Middle East & Africa Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 101. United States Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 102. United States Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 103. Canada Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 104. Canada Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 105. Mexico Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 106. Mexico Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 107. Brazil Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 108. Brazil Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 109. China Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 110. China Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 111. Japan Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 112. Japan Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 113. Korea Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 114. Korea Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 116. Southeast Asia Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 117. India Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 118. India Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 119. Australia Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 120. Australia Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 121. Germany Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 122. Germany Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 123. France Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 124. France Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 125. UK Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 126. UK Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 127. Italy Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 128. Italy Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 129. Russia Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 130. Russia Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 131. Spain Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 132. Spain Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 133. Egypt Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 134. Egypt Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 135. South Africa Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 136. South Africa Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 137. Israel Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 138. Israel Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 139. Turkey Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 140. Turkey Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Intravenous Solutions Consumption 2021-2025 (M Units)
Figure 142. GCC Countries Intravenous Solutions Value 2021-2025 ($ Millions)
Figure 143. Baxter Intravenous Solutions Market Share (2018-2020)
Figure 144. Kelun Group Intravenous Solutions Market Share (2018-2020)
Figure 145. Otsuka Intravenous Solutions Market Share (2018-2020)
Figure 146. ICU Medical Intravenous Solutions Market Share (2018-2020)
Figure 147. Fresenius Kabi Intravenous Solutions Market Share (2018-2020)
Figure 148. B. Braun Melsungen Intravenous Solutions Market Share (2018-2020)
Figure 149. Fresenius Kabi Intravenous Solutions Market Share (2018-2020)
Figure 150. JW Life Science Intravenous Solutions Market Share (2018-2020)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs